Modulating factors of fibromyalgia in women during the COVID-19 pandemic: a protocol for systematic review
Loading...
Publication date
Advisors
Research group
Center
Abstract
Background:
Fibromyalgia is a disease that affects mostly women and is related to stressors. The aim of this study was to assess how the Coronavirus disease 2019 pandemic has affected women with fibromyalgia.
Methods:
A systematic review was conducted in the PubMed, ScienceDirect, and Springer Link databases, following the recommendations of the preferred reporting items for systematic reviews and meta-analyses statement. The methodological quality was assessed using the Joanna Briggs Institute critical appraisal tools for non-randomized studies.
Results:
A total of 6 studies were included. Most results indicated a worsening in the mental health of women with fibromyalgia during the pandemic, and this in turn impacted on physical health.
Conclusion:
The mental health of women with fibromyalgia was more affected during the Coronavirus disease 2019 pandemic period than that of non-fibromyalgia sufferers. This was also reflected in the worsening of symptoms and weakness in performing daily activities.
Unesco Subjects
Bibliographic citation
Núñez-Recio, I., García-Iglesias, J. J., Martín-López, C., Navarro-Abal, Y., Fagundo-Rivera, J., Climent-Rodríguez, J. A., & Gómez-Salgado, J. (2022). Modulating factors of fibromyalgia in women during the COVID-19 pandemic: A protocol for systematic review. In Medicine (Vol. 101, Issue 52, p. e32577). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/md.0000000000032577














